JAMA + AI Weekly Update May 9, 2025

Editor’s Picks in this week’s JAMA+ AI:

• A Viewpoint in JAMA Oncology explores the rise of social media and AI in oncology, which has transformed scientific communication but also poses risks for bias, misinterpretation, and financial conflicts of interest.
• A study published in JAMA Network Open provides insight into why some patients choose not to learn their Alzheimer Disease research biomarker results.
• A systematic review published in JAMA Network Open found that most prescribable digital health technologies are designed for single conditions, suggesting patients with multiple chronic conditions would need to use numerous devices and apps concurrently to achieve comprehensive health benefits.